Gevilon
Brand names,
Gevilon
Analogs
Gevilon
Brand Names Mixture
Gevilon
Chemical_Formula
C15H22O3
Gevilon
RX_link
http://www.rxlist.com/cgi/generic/gemfib.htm
Gevilon
fda sheet
Gevilon
msds (material safety sheet)
Gevilon
Synthesis Reference
P. L. CREGER, U.S. Pat. 3,674,836 (1972)
Gevilon
Molecular Weight
250.333 g/mol
Gevilon
Melting Point
61-63 oC
Gevilon
H2O Solubility
10 mg/mL (in base)
Gevilon
State
Solid
Gevilon
LogP
4.242
Gevilon
Dosage Forms
Tablets; Capsules
Gevilon
Indication
For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.
Gevilon
Pharmacology
Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce triglyceride levels, reduce VLDL levels, reduce LDL levels (moderately), and increase HDL levels (moderately).
Gevilon
Absorption
Well absorbed from gastrointestinal tract (within 1-2 hours).
Gevilon
side effects and Toxicity
Oral, mouse: LD50 = 3162 mg/kg. Symptoms of overdose include abdominal cramps, diarrhea, joint and muscle pain, nausea, and vomiting.
Gevilon
Patient Information
Gemfibrozil is used to lower high triglyceride and cholesterol levels. Notify your physician if you are pregnant
or nursing. Gemfibrozil should be taken 30 minutes before the morning and evening meals. This medication may cause
dizziness or blurred vision; use caution while driving or operating hazardous machinery. Gemfibrozil may cause an
increase in blood sugar. If you have diabetes mellitus, carefully monitor blood sugar levels. Notify your physician
if you develop severe stomach pain, muscle pain or weakness, or unexplained fever.
Gevilon
Organisms Affected
Humans and other mammals